6 Apr 2017 16:13
6 April 2017
AIM: AMYT
ESM: AYP
Amryt Pharma plc
("Amryt" or the "Company")
Posting of Annual Report 2016 and Notice of AGM
Amryt, the pharmaceutical company focused on best-in-class treatments for rare and orphan diseases, announces that copies of the Annual Report for the year ended 31 December 2016 have today been sent to shareholders along with the Notice of Annual General Meeting ("AGM"). Copies are also available from the Company's website, www.amrytpharma.com.
The AGM will be held at 9am on 25 May 2017 at Holiday Inn London Mayfair, 3 Berkeley Street, Mayfair, London W1J 8NE.
Enquiries:
Amryt Pharma plc | C/o KTZ Communications |
Joe Wiley, CEO Rory Nealon, CFO/COO
|
|
|
|
Shore Capital | +44 (0) 20 7408 4090 |
Nomad and Joint Broker |
|
Bidhi Bhoma, Edward Mansfield
|
|
|
|
Davy | +353 (1) 679 6363 |
ESM Adviser and Joint Broker |
|
John Frain, Anthony Farrell
|
|
Stifel | +44 (0) 20 7710 7600 |
Joint Broker |
|
Jonathan Senior, Ben Maddison
|
|
KTZ Communications | +44 (0) 20 3178 6378 |
Katie Tzouliadis, Emma Pearson |
|
AMYT.L (AMYT)